$37.71
0.762.05%
After Hours: Jan 16, 9:27 AM EST
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Comments
Loading...
Franklin Genomic Advancements ETF (HELX) Stock Price, Quote, News & History
HELXBATS
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Sector
Healthcare
Region
US
AUM
22.16M
Fund Score
Key Statistics
Open
$36.65
High
$36.65
52 Wk High
$38.17
AUM
22.16M
Dividend
$0.14
Ex-Div Date
Dec 30, 2025
Volume
1.36K
Market Cap
$40.62B
Mgmt Fee
0.5%
P/E Ratio
29.41
Prev. Close
$36.95
Low
$36.65
52 Wk Low
$23.74
Shares Out
300.00K
Yield
0.39%
Div. Freq
-
Avg. Volume Daily
1.98K
Beta
1.05
Avg. Expense Ratio
0.5%
P/B Ratio
4.79
Recent Franklin Genomic Advancements ETF News
FAQ
Q
How do I buy Franklin Genomic Advancements ETF (HELX) stock?
A
You can purchase shares of Franklin Genomic Advancements ETF (BATS:HELX) through any online brokerage.
Q
Who are Franklin Genomic Advancements ETF (HELX) competitors?
A
There are no as such competitors for Franklin Genomic Advancements ETF.
Q
What is the forecast, or price target, for Franklin Genomic Advancements ETF (HELX) stock?
A
There is no analysis for Franklin Genomic Advancements ETF to provide a consensus price target.
Q
What is the current price for Franklin Genomic Advancements ETF (HELX)?
A
The stock price for Franklin Genomic Advancements ETF (BATS: HELX) is $37.71 last updated January 16, 2026 at 9:27 AM EST.
Q
Does Franklin Genomic Advancements ETF (HELX) pay a dividend?
A
There are no upcoming dividends for Franklin Genomic Advancements ETF.
Q
When is Franklin Genomic Advancements ETF (BATS:HELX) reporting earnings?
A
Franklin Genomic Advancements ETF does not have any upcoming earnings scheduled.
Q
Is Franklin Genomic Advancements ETF (HELX) going to split?
A
There is no upcoming split for Franklin Genomic Advancements ETF.
Key Statistics
Open
$36.65
High
$36.65
52 Wk High
$38.17
AUM
22.16M
Dividend
$0.14
Ex-Div Date
Dec 30, 2025
Volume
1.36K
Market Cap
$40.62B
Mgmt Fee
0.5%
P/E Ratio
29.41
Prev. Close
$36.95
Low
$36.65
52 Wk Low
$23.74
Shares Out
300.00K
Yield
0.39%
Div. Freq
-
Avg. Volume Daily
1.98K
Beta
1.05
Avg. Expense Ratio
0.5%
P/B Ratio
4.79
About
Sector
N/A
Industry
N/A
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Mid Cap Growth |
| Fund Inception | Feb 25, 2020 |
| Managers | Matthew J. Moberg |
| Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
Investment Policy
The Fund invests in equity securities inside and outside of the United States, including developing or emerging markets.
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| MEDP | Medpace Holdings Inc | 4.45% |
| KRYS | Krystal Biotech Inc | 4.60% |
| NTRA | Natera Inc | 6.88% |
| UTHR | United Therapeutics Co... | 3.52% |
| ALNY | Alnylam Pharmaceutical... | 3.62% |
| GH | Guardant Health Inc | 6.74% |
| INSM | Insmed Inc | 4.43% |
| ADPT | Adaptive Biotechnologi... | 3.23% |
| BBIO | Bridgebio Pharma Inc | 4.02% |
| KR | Samsung Biologics Co L... | 3.21% |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved